SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
SEC Accession No. 0001140361-22-011363
Filing Date
2022-03-28
Accepted
2022-03-28 16:28:46
Documents
8
Effectiveness Date
2022-03-28

Document Format Files

Seq Description Document Type Size
1 POSASR ny20003563x1_posasr.htm POSASR 655281
2 EXHIBIT 5.1 ny20003563x1_ex5-1.htm EX-5.1 26280
3 EXHIBIT 23.1 ny20003563x1_ex23-1.htm EX-23.1 1703
4 FILING FEES ny20003563x1_ex107.htm EX-FILING FEES 47633
5 logo_kinnatebiopharma.jpg GRAPHIC 63964
6 logo_kinnatebiopharmax1.jpg GRAPHIC 49060
7 logo_kinnatebiopharmax2.jpg GRAPHIC 57272
8 ny20003563x1_ex5-1img01.jpg GRAPHIC 125723
  Complete submission text file 0001140361-22-011363.txt   1139182
Mailing Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130
Business Address 11975 EL CAMINO REAL, STE 101 SAN DIEGO CA 92130 8582994699
Kinnate Biopharma Inc. (Filer) CIK: 0001797768 (see all company filings)

IRS No.: 824566526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POSASR | Act: 33 | File No.: 333-261970 | Film No.: 22775807
SIC: 2834 Pharmaceutical Preparations